comparemela.com

Hepatitisc Drug News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Hepatitis C Drug Market Size & Share to Surpass $56 5 Billion by 2030

WASHINGTON, Aug. 17, 2023 (GLOBE NEWSWIRE) According to Vantage Market Research, the Global Hepatitis C Drug Market is estimated to be valued at USD 56.5 Billion by 2030 and is expected to exhibit a CAGR of 14.5% from 2023 to 2030. The global Hepatitis C Drug Market grew to USD 21.9 Billion in 2022. As per Vantage Market Research, the global Hepatitis C Drug Market has been steadily growing due to the increasing prevalence of hepatitis C infections and the introduction of innovative drugs wit

Malaysia Healthcare Travel Council: Malaysia, First in the South East Asia to Offer Affordable and Efficacious Hepatitis C Treatment Solution

Malaysia, First in the South East Asia to Offer Affordable and Efficacious Hepatitis C Treatment Solution

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.